Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

NCCN Guidelines Insights: Antiemesis, Version 2.2017.

Berger MJ, Ettinger DS, Aston J, Barbour S, Bergsbaken J, Bierman PJ, Brandt D, Dolan DE, Ellis G, Kim EJ, Kirkegaard S, Kloth DD, Lagman R, Lim D, Loprinzi C, Ma CX, Maurer V, Michaud LB, Nabell LM, Noonan K, Roeland E, Rugo HS, Schwartzberg LS, Scullion B, Timoney J, Todaro B, Urba SG, Shead DA, Hughes M.

J Natl Compr Canc Netw. 2017 Jul;15(7):883-893. doi: 10.6004/jnccn.2017.0117.

PMID:
28687576
2.

Tolerability of Gemcitabine Plus Cisplatin for Treatment of Urothelial Cancer in the Elderly Population.

Jan AS, Dolan DE, Lombardi K, Gupta S.

Clin Genitourin Cancer. 2016 Jun;14(3):e257-63. doi: 10.1016/j.clgc.2015.09.003. Epub 2015 Sep 25.

PMID:
26462439
3.

PD-1 pathway inhibitors: changing the landscape of cancer immunotherapy.

Dolan DE, Gupta S.

Cancer Control. 2014 Jul;21(3):231-7. Review.

PMID:
24955707

Supplemental Content

Loading ...
Support Center